List of works - Todd M. Hulgan

A randomized trial of Raltegravir replacement for protease inhibitor or non-nucleoside reverse transcriptase inhibitor in HIV-infected women with lipohypertrophy.

scientific article

Active cocaine use is associated with lack of HIV-1 virologic suppression independent of nonadherence to antiretroviral therapy: use of a rapid screening tool during routine clinic visits

scientific article

Adipose Tissue and Immune Function: A Review of Evidence Relevant to HIV Infection ⬇️

scientific article published on July 21, 2013

African mitochondrial DNA subhaplogroups and peripheral neuropathy during antiretroviral therapy

scientific article

Agreement of decision analyses and subsequent clinical studies in infectious diseases

scientific article published in May 2007

An association between adiposity and serum levels of macrophage inflammatory protein-1α and soluble CD14 in HIV-infected adults: results from a cross-sectional study

scientific article published on 07 June 2013

Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era

scientific article published on 21 December 2015

Anthropometric Differences between HIV-Infected Individuals Prior to Antiretroviral Treatment and the General Population from 1998–2007: The AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (ALLRT) Cohort and NHANES ⬇️

scientific article published on June 3, 2013

Cerebrospinal fluid (CSF) biomarkers of iron status are associated with CSF viral load, antiretroviral therapy, and demographic factors in HIV-infected adults

scientific article

Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment

scientific article published on 31 March 2017

Chronic kidney disease at presentation is not an independent risk factor for AIDS-defining events or death in HIV-infected persons

scientific article published on February 2013

Circulating interleukin-6, soluble CD14, and other inflammation biomarker levels differ between obese and nonobese HIV-infected adults on antiretroviral therapy

scientific article published on 11 April 2013

Clinical factors associated with plasma F2-isoprostane levels in HIV-infected adults

scientific article

Cross-cohort heterogeneity encountered while validating a model for HIV disease progression among antiretroviral initiators

scientific article published on 23 December 2008

Current drug use and lack of HIV virologic suppression: point-of-care urine drug screen versus self-report

scientific article

Drug use and receipt of highly active antiretroviral therapy among HIV-infected persons in two U.S. clinic cohorts

scientific article

Epidermal nerve fiber density, oxidative stress, and mitochondrial haplogroups in HIV-infected Thais initiating therapy

scientific article published on July 2014

Estimating the optimal CD4 count for HIV-infected persons to start antiretroviral therapy

scientific article

European Mitochondrial DNA Haplogroups are Associated with Cerebrospinal Fluid Biomarkers of Inflammation in HIV Infection

scientific article published on September 2016

European mitochondrial DNA haplogroups and metabolic changes during antiretroviral therapy in AIDS Clinical Trials Group Study A5142

scientific article

Genetic variation in iron metabolism is associated with neuropathic pain and pain severity in HIV-infected patients on antiretroviral therapy

scientific article

Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study

scientific article published on 26 April 2017

Hemochromatosis (HFE) Gene Variants Are Associated with Increased Mitochondrial DNA Levels During HIV-1 Infection and Antiretroviral Therapy

scientific article published on 22 August 2018

Hemochromatosis (HFE) gene mutations and peripheral neuropathy during antiretroviral therapy

scientific article published on 01 July 2006

Hemochromatosis gene polymorphisms, mitochondrial haplogroups, and peripheral lipoatrophy during antiretroviral therapy

scientific article published in March 2008

Higher plasma myeloperoxidase levels are not associated with an increased risk for cardiovascular events in HIV-infected adults

scientific article

Higher serum iron is associated with increased oxidant stress in HIV-infected men

scientific article published on December 2013

Highly sensitive C-reactive protein, body mass index, and serum lipids in HIV-infected persons receiving antiretroviral therapy: a longitudinal study

scientific article published on December 2009

Human genomic association studies: a primer for the infectious diseases specialist

scientific article published on 9 May 2007

Identification of a CCR5-expressing T cell subset that is resistant to R5-tropic HIV infection

scientific article

Iron-regulatory genes are associated with Neuroimaging measures in HIV infection

scientific article published on 03 July 2019

Mitochondrial DNA Haplogroups and Neurocognitive Impairment During HIV Infection

scientific article

Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTER.

scientific article published on 17 October 2012

Mitochondrial DNA variation and changes in adiponectin and endothelial function in HIV-infected adults after antiretroviral therapy initiation

scientific article published on 14 August 2013

Mitochondrial Genomics and CD4 T-Cell Count Recovery After Antiretroviral Therapy Initiation in AIDS Clinical Trials Group Study 384 ⬇️

scientific article published on December 1, 2011

Mitochondrial Haplogroups as a Risk Factor for Herpes Zoster.

scientific article published on 19 October 2016

Mitochondrial genomics and antiretroviral therapy-associated metabolic complications in HIV-infected Black South Africans: a pilot study

scientific article published on 15 March 2013

Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study

scientific article published on September 2005

Oral cyclosporin A inhibits CD4 T cell P-glycoprotein activity in HIV-infected adults initiating treatment with nucleoside reverse transcriptase inhibitors

scientific article

Peripheral Blood Mitochondrial DNA Copy Number Obtained From Genome-Wide Genotype Data Is Associated With Neurocognitive Impairment in Persons With Chronic HIV Infection

scientific article published on 01 April 2019

Pharmacogenetics of nucleoside reverse-transcriptase inhibitor-associated peripheral neuropathy

scientific article published on April 2009

Pharmacogenomics of antimicrobial agents

scientific article

Postpartum discontinuation of antiretroviral therapy and risk of maternal AIDS-defining events, non-AIDS-defining events, and mortality among a cohort of HIV-1-infected women in the United States

scientific article

Race, kidney disease progression, and mortality risk in HIV-infected persons

scientific article

Serum leptin level mediates the association of body composition and serum C-reactive protein in HIV-infected persons on antiretroviral therapy

scientific article

Sex differences in urinary biomarkers of vascular and endothelial function in HIV-infected persons receiving antiretroviral therapy

scientific article published on 14 December 2011

Sociodemographic factors predict early discontinuation of HIV non-nucleoside reverse transcriptase inhibitors and protease inhibitors

scientific article published on December 2008

Switch to Raltegravir From Protease Inhibitor or Nonnucleoside Reverse-Transcriptase Inhibitor Does not Reduce Visceral Fat In Human Immunodeficiency Virus-Infected Women With Central Adiposity

scientific article

T Cell Activation Markers and African Mitochondrial DNA Haplogroups among Non-Hispanic Black Participants in AIDS Clinical Trials Group Study 384 ⬇️

scientific article published on August 27, 2012

The relationship between injection and noninjection drug use and HIV disease progression

scientific article

Urinary eicosanoid metabolites in HIV-infected women with central obesity switching to raltegravir: an analysis from the women, integrase, and fat accumulation trial.

scientific article

Urine Eicosanoids in the Metabolic Abnormalities, Telmisartan, and HIV Infection (MATH) Trial

scientific article

List of works by Todd M. Hulgan

A randomized trial of Raltegravir replacement for protease inhibitor or non-nucleoside reverse transcriptase inhibitor in HIV-infected women with lipohypertrophy.

Active cocaine use is associated with lack of HIV-1 virologic suppression independent of nonadherence to antiretroviral therapy: use of a rapid screening tool during routine clinic visits

Adipose Tissue and Immune Function: A Review of Evidence Relevant to HIV Infection ⬇️

African mitochondrial DNA subhaplogroups and peripheral neuropathy during antiretroviral therapy

Agreement of decision analyses and subsequent clinical studies in infectious diseases

An association between adiposity and serum levels of macrophage inflammatory protein-1α and soluble CD14 in HIV-infected adults: results from a cross-sectional study

Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era

Anthropometric Differences between HIV-Infected Individuals Prior to Antiretroviral Treatment and the General Population from 1998–2007: The AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (ALLRT) Cohort and NHANES ⬇️

Cerebrospinal fluid (CSF) biomarkers of iron status are associated with CSF viral load, antiretroviral therapy, and demographic factors in HIV-infected adults

Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment

Chronic kidney disease at presentation is not an independent risk factor for AIDS-defining events or death in HIV-infected persons

Circulating interleukin-6, soluble CD14, and other inflammation biomarker levels differ between obese and nonobese HIV-infected adults on antiretroviral therapy

Clinical factors associated with plasma F2-isoprostane levels in HIV-infected adults

Cross-cohort heterogeneity encountered while validating a model for HIV disease progression among antiretroviral initiators

Current drug use and lack of HIV virologic suppression: point-of-care urine drug screen versus self-report

Drug use and receipt of highly active antiretroviral therapy among HIV-infected persons in two U.S. clinic cohorts

Epidermal nerve fiber density, oxidative stress, and mitochondrial haplogroups in HIV-infected Thais initiating therapy

Estimating the optimal CD4 count for HIV-infected persons to start antiretroviral therapy

European Mitochondrial DNA Haplogroups are Associated with Cerebrospinal Fluid Biomarkers of Inflammation in HIV Infection

European mitochondrial DNA haplogroups and metabolic changes during antiretroviral therapy in AIDS Clinical Trials Group Study A5142

Genetic variation in iron metabolism is associated with neuropathic pain and pain severity in HIV-infected patients on antiretroviral therapy

Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study

Hemochromatosis (HFE) Gene Variants Are Associated with Increased Mitochondrial DNA Levels During HIV-1 Infection and Antiretroviral Therapy

Hemochromatosis (HFE) gene mutations and peripheral neuropathy during antiretroviral therapy

Hemochromatosis gene polymorphisms, mitochondrial haplogroups, and peripheral lipoatrophy during antiretroviral therapy

Higher plasma myeloperoxidase levels are not associated with an increased risk for cardiovascular events in HIV-infected adults

Higher serum iron is associated with increased oxidant stress in HIV-infected men

Highly sensitive C-reactive protein, body mass index, and serum lipids in HIV-infected persons receiving antiretroviral therapy: a longitudinal study

Human genomic association studies: a primer for the infectious diseases specialist

Identification of a CCR5-expressing T cell subset that is resistant to R5-tropic HIV infection

Iron-regulatory genes are associated with Neuroimaging measures in HIV infection

Mitochondrial DNA Haplogroups and Neurocognitive Impairment During HIV Infection

Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTER.

Mitochondrial DNA variation and changes in adiponectin and endothelial function in HIV-infected adults after antiretroviral therapy initiation

Mitochondrial Genomics and CD4 T-Cell Count Recovery After Antiretroviral Therapy Initiation in AIDS Clinical Trials Group Study 384 ⬇️

Mitochondrial Haplogroups as a Risk Factor for Herpes Zoster.

Mitochondrial genomics and antiretroviral therapy-associated metabolic complications in HIV-infected Black South Africans: a pilot study

Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study

Oral cyclosporin A inhibits CD4 T cell P-glycoprotein activity in HIV-infected adults initiating treatment with nucleoside reverse transcriptase inhibitors

Peripheral Blood Mitochondrial DNA Copy Number Obtained From Genome-Wide Genotype Data Is Associated With Neurocognitive Impairment in Persons With Chronic HIV Infection

Pharmacogenetics of nucleoside reverse-transcriptase inhibitor-associated peripheral neuropathy

Pharmacogenomics of antimicrobial agents

Postpartum discontinuation of antiretroviral therapy and risk of maternal AIDS-defining events, non-AIDS-defining events, and mortality among a cohort of HIV-1-infected women in the United States

Race, kidney disease progression, and mortality risk in HIV-infected persons

Serum leptin level mediates the association of body composition and serum C-reactive protein in HIV-infected persons on antiretroviral therapy

Sex differences in urinary biomarkers of vascular and endothelial function in HIV-infected persons receiving antiretroviral therapy

Sociodemographic factors predict early discontinuation of HIV non-nucleoside reverse transcriptase inhibitors and protease inhibitors

Switch to Raltegravir From Protease Inhibitor or Nonnucleoside Reverse-Transcriptase Inhibitor Does not Reduce Visceral Fat In Human Immunodeficiency Virus-Infected Women With Central Adiposity

T Cell Activation Markers and African Mitochondrial DNA Haplogroups among Non-Hispanic Black Participants in AIDS Clinical Trials Group Study 384 ⬇️

The relationship between injection and noninjection drug use and HIV disease progression

Urinary eicosanoid metabolites in HIV-infected women with central obesity switching to raltegravir: an analysis from the women, integrase, and fat accumulation trial.

Urine Eicosanoids in the Metabolic Abnormalities, Telmisartan, and HIV Infection (MATH) Trial